Pharmacological intervention for cognitive deficits and aggression in frontal lobe injury

NeuroRehabilitation. 2006;21(1):3-7.

Abstract

We present a case that promotes early intervention and pharmacological treatment for the neuropsychiatric sequelae (frontal lobe syndrome, including cognitive impairment and aggressive behavior) associated with traumatic brain injury (TBI) and delirium. The patient, who sustained significant systemic complications related to his trauma, was previously diagnosed with alcohol and drug dependence and antisocial personality disorder. These antecedent conditions and prolonged systemic complications likely played a complicating role in his course of recovery.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aggression*
  • Amantadine / therapeutic use
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / etiology
  • Conduct Disorder / drug therapy*
  • Conduct Disorder / etiology
  • Donepezil
  • Frontal Lobe / injuries*
  • Humans
  • Indans / therapeutic use
  • Male
  • Neurotransmitter Agents / therapeutic use*
  • Nootropic Agents / therapeutic use*
  • Piperidines / therapeutic use
  • Valproic Acid / therapeutic use

Substances

  • Indans
  • Neurotransmitter Agents
  • Nootropic Agents
  • Piperidines
  • Valproic Acid
  • Donepezil
  • Amantadine